Rivaroxaban, COVID-19, and VTE With Victor Tapson, MD (Part 2)

Victor F. Tapson, MD, Professor of Medicine and Associate Director of Pulmonary Critical Care, and Director of Venous Thromboembolism (VTE) Research at Cedars-Sinai Medical Center in Los Angeles, talks about the use of rivaroxaban in the treatment of VTE, as well as how COVID-19 has affected treatment of his patients.

This is the second part of a two-part interview. Part 1 of this interview can be viewed here.